HOUSE CONCURRENT RESOLUTION NO. 42 103RD GENERAL ASSEMBLY INTRODUCED BY REPRESENTATIVE PERKINS. 6998H.01I JOSEPH ENGLER, Chief Clerk
WHEREAS, rising health care costs remain a significant concern for Missouri 2 families, employers, and communities, and improving affordability is a top priority for all 3 Missourians and Americans; and 4 5 WHEREAS, American patients have subsidized innovation and low-cost prescription 6 drugs for wealthy foreign countries who must start to pay their fair share; and 7 8 WHEREAS, President Donald J. Trump has taken creative actions aimed at 9 improving the affordability of health care for Missourians and all Americans while protecting 10 U.S. leadership in global medical innovation and investment in research and development; 11 and 12 13 WHEREAS, the Trump Administration intends to leverage federal trade authorities to 14 ensure foreign nations pay more for prescription drugs and announced agreements to bring 15 lower medicine prices to U.S. patients; and 16 17 WHEREAS, on September 30, 2025, President Trump announced TrumpRx, an 18 online direct-purchasing platform that aims to connect American patients with lower prices 19 for their prescription medications, increase transparency, and bypass supply chain 20 middlemen; and 21 22 WHEREAS, it is essential that Missouri patients who choose to secure their 23 medications through TrumpRx do not forfeit access to the health plan benefits that they 24 already pay for; and 25 HCR 42 2
26 WHEREAS, Missourians who use TrumpRx could be steered back to higher-cost 27 channels if their cash-pay expenses are not applied toward their health plan deductibles and 28 out-of-pocket maximums; and 29 30 WHEREAS, safeguarding health insurance coverage and ensuring parity for all 31 patient out-of-pocket prescription drug costs would promote market competition and 32 complement the Trump Administration's efforts to improve affordability; and 33 34 WHEREAS, on November 6, 2025, the Centers for Medicare & Medicaid Services 35 announced the GENErating cost Reductions fOr U.S. Medicaid (GENEROUS) Model to 36 enable state Medicaid programs to voluntarily access lower drug prices through federally 37 negotiated supplemental rebates; and 38 39 WHEREAS, the GENEROUS Model may offer Missouri and MO HealthNet a 40 pathway to achieve significant cost savings from federal agreements: 41 42 NOW THEREFORE BE IT RESOLVED that the members of the House of 43 Representatives of the One Hundred Third General Assembly, Second Regular Session, the 44 Senate concurring therein, hereby express support for TrumpRx and encourage the U.S. 45 Department of Health and Human Services to act to prevent discriminatory insurance 46 practices and require health insurance plans and pharmacy benefits managers to apply all 47 patient-paid prescription drug expenditures, including those obtained through TrumpRx and 48 similar direct-purchasing platforms, toward patients' cost-sharing requirements, such as 49 deductibles and out-of-pocket maximums; and 50 51 BE IT FURTHER RESOLVED that the Missouri General Assembly strongly urges 52 health insurers and pharmacy benefits managers to announce that they will apply all patient- 53 paid prescription drug expenditures, including those obtained through TrumpRx and similar 54 direct-purchasing platforms, toward patients' cost-sharing requirements, such as deductibles 55 and out-of-pocket maximums; and 56 57 BE IT FURTHER RESOLVED that the Missouri General Assembly requests that 58 the Missouri Department of Health and Senior Services assess the GENEROUS Model and 59 report and remove any barriers that would prevent or delay MO HealthNet's participation to 60 ensure that Missouri can realize potential cost savings; and 61 HCR 42 3
62 BE IT FURTHER RESOLVED that the Chief Clerk of the Missouri House of 63 Representatives be instructed to prepare a properly inscribed copy of this resolution for the 64 President of the United States, the United States Secretary of Health and Human Services, and 65 each member of the Missouri Congressional delegation. ✔